Pharmacophore Modeling for Identification of Anti-Igf-1r Drugs and In-Vitro Validation of Fulvestrant as a Potential Inhibitor

PLoS ONE - United States
doi 10.1371/journal.pone.0196312
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

IGF-1R as an Anti-Cancer Target--Trials and Tribulations

Chinese Journal of Cancer
2013English

Icaritin, a Novel FASN Inhibitor, Exerts Anti-Melanoma Activities Through IGF-1R/STAT3 Signaling

Oncotarget
Oncology
2016English

Identification of New Potential APE1 Inhibitors by Pharmacophore Modeling and Molecular Docking

Genomics and Informatics
EvolutionEcologyGeneticsSystematicsHealth InformaticsBehavior
2017English

Identification of a New Class of Natural Product MDM2 Inhibitor: In Vitro and in Vivo Anti-Breast Cancer Activities and Target Validation

Oncotarget
Oncology
2015English

Can We Unlock the Potential of IGF-1R Inhibition in Cancer Therapy?

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2014English

Revisiting the IGF-1R as a Breast Cancer Target

npj Precision Oncology
2017English

Molecular Modeling of Anti HIV Drugs of Protease Inhibitor Group by CoMFA

International Journal of Recent Technology and Engineering
EngineeringManagement of TechnologyInnovation
2019English

Molecular Imaging of IGF-1R in Cancer

Molecular Imaging
Nuclear MedicineRadiologyMolecular MedicineCondensed Matter PhysicsImagingBiotechnologyBiomedical Engineering
2017English

Identification of Anti-Inflammatory and Anti-Hypertensive Drugs as Inhibitors of Bacterial Diguanylate Cyclases

Journal of the Brazilian Chemical Society
Chemistry
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy